Medical Program: cardiac mitotrope ninerafaxstat in nHCM

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
ACC.24 - There is an unmet treatment need for nonobstructive hypertrophic cardiomyopathy (nHCM). Martin Maron shares the results of IMPROVE-HCM, which evaluated the efficacy and safety of the novel cardiac mitotrope ninerafaxstat in nHCM.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Martin Maron, MD is Director of the Hypertrophic Cardiomyopathy Center Lahey Medical Center and Hospital in Burglington, MA, US. He also is Board Director at the Chanin T. Mast Hypertrophic Cardiomyopathy Center in Morristown Medical Center, Morristown, NJ, VS.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of IMPROVE-HCM
Release date: 22 April 2024

Recommended

Details

Presenters

Overview
ACC.24 - There is an unmet treatment need for nonobstructive hypertrophic cardiomyopathy (nHCM). Martin Maron shares the results of IMPROVE-HCM, which evaluated the efficacy and safety of the novel cardiac mitotrope ninerafaxstat in nHCM.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Martin Maron, MD is Director of the Hypertrophic Cardiomyopathy Center Lahey Medical Center and Hospital in Burglington, MA, US. He also is Board Director at the Chanin T. Mast Hypertrophic Cardiomyopathy Center in Morristown Medical Center, Morristown, NJ, VS.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of IMPROVE-HCM
Release date: 22 April 2024

Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM